Skip to main content
Fig. 7 | Nano Convergence

Fig. 7

From: Transmissible H-aggregated NIR-II fluorophore to the tumor cell membrane for enhanced PTT and synergistic therapy of cancer

Fig. 7

In vivo NIR-II FI and PTI of RRIALP-C4. a In vivo NIR-II FI of RRIALP-C4 at different time points (0, 1, 3, 6, 12, 24 h). b In vivo NIR-II FI of different liposomes after projection for 12 h. c, d Fluorescence intensities of different liposomes in liver, spleen, and tumor after projection for 12 h. I: IALP-C4. II: RIALP-C4. III: TIALP-C4. IV: RRIALP-C4. e In vivo PTI of RRIALP-C4 at different time points (0, 15, 30, 60, 90, 120, 180, 240 s). f In vivo PTI of different liposomes after irradiation for 240 s. g Distributions of RRIAP-C4 in different organs after treatment for 24 h

Back to article page